D. Fintel

发表

Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease.

D. Singer, W. Remme, D. V. van Hoogenhuyze, 1991, The American journal of cardiology.

Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.

Deepak L. Bhatt, L. Newby, C. Cannon, 2006, Archives of internal medicine.

Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.

R. Califf, W. Gibler, E. Ohman, 2006, Archives of internal medicine.

Overweight and obesity: the pathogenesis of cardiometabolic risk.

G. Bray, D. Fintel, M. Clearfield, 2009, Clinical cornerstone.

Reduced mortality rates after intensive statin therapy in managed-care patients.

D. Fintel, D. Ollendorf, J. Graff, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Antiplatelet Therapy in Cerebrovascular Disease: Implications of MATCH and CHARISMA Results for Cardiologists

D. Fintel, 2007 .

From bench to bedside: GP IIb–IIIa inhibitors

D. Fintel, Dan J. Fintel, 2001, Neurology.

Risk factors in siblings of people with premature coronary heart disease.

L. Becker, D. Becker, D. Levine, 1988, Journal of the American College of Cardiology.

Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementa

C. Cannon, W. Gibler, E. Ohman, 2008, American Heart Journal.

Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency

D. Fintel, C. Rammohan, 2003, Current cardiology reports.

Management of patients with non—ST‐segment elevation acute coronary syndromes: Insights from the pursuit trial

D. Fintel, G. Ledley, 2000, Clinical cardiology.

Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.

D. Fintel, Michael W. Tempelhof, K. Benzuly, 2012, Texas Heart Institute journal.

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction

Y. Rosenberg, P. Greenland, D. Bello, 2021, Journal of the American Heart Association.

Comparison of Metoprolol versus Carvedilol After Acute Myocardial Infarction.

H. Subacius, J. Goldberger, D. Fintel, 2021, The American journal of cardiology.

Screening of asymptomatic siblings of patients with premature coronary artery disease

L. Becker, D. Becker, D. Fintel, 1987, Circulation.

1135-72 Higher mortality and less evidence-based therapies among medicaid-insured patients with high-risk acute coronary syndromes: Results from CRUSADE

E. DeLong, W. Gibler, E. Ohman, 2004 .

Organization and staffing practices in US cardiac intensive care units: a survey on behalf of the American Heart Association Writing Group on the Evolution of Critical Care Cardiology

C. Granger, D. Morrow, S. Murphy, 2013, European heart journal. Acute cardiovascular care.

The effect of clonidine on the cessation of cigarette smoking

D. Fintel, M. Parker, R. Davison, 1988, Clinical pharmacology and therapeutics.

Antiplatelet therapy in cerebrovascular disease: implications of Management of Artherothrombosis with Clopidogrel in High-risk Patients and the Clopidogrel for High Artherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance studies' results for cardiologists.

D. Fintel, 2007, Clinical cardiology.

Drug eruptions and isotypic antibody responses to streptokinase after infusions of anisoylated plasminogen-streptokinase complex (APSAC, anistreplase).

D. Fintel, M. Dykewicz, R. Davison, 1995, The Journal of allergy and clinical immunology.

Studies on two novel angiotensin II actions.

E. Haber, R. Re, D. Fintel, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Insurance Coverage and Care of Patients with NonST-Segment Elevation Acute Coronary Syndromes

E. DeLong, W. Gibler, E. Ohman, 2006, Annals of Internal Medicine.

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.

Catherine P. Benziger, M. Pencina, G. Fonarow, 2020, JAMA cardiology.

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

R. Califf, E. Topol, K. Anderson, 1994, The Lancet.

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

E J Topol, R. Califf, E. Topol, 1994, Lancet.

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.

James R. Campbell, Laura G. Qualls, M. Pencina, 2021, The New England journal of medicine.

Management of high-risk subsets in unstable angina.

D. Saurí, M. Gheorghiade, D. Fintel, 1999, Cardiology clinics.

Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.

L. Becker, P. Shah, D. Morris, 1992, Journal of the American College of Cardiology.

Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association.

C. Granger, D. Morrow, J. López-Sendón, 2012, Circulation.

Scientific Statement From the American Heart Association Care Unit and the Emerging Need for New Medical Staffing and Training Models : A Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive

C. Granger, D. Morrow, J. López-Sendón, 2012 .

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options

D. Fintel, 2012, Vascular health and risk management.

The Role of RAS Modification for Primary and Secondary Stroke Prevention

D. Fintel, 2009, Postgraduate medicine.

Low heart rate variability and sudden cardiac death.

D H Singer, G J Martin, D. Singer, 1988, Journal of electrocardiology.

The Burden of PAD: Diagnosis and contemporary medical management through risk-factor modification

D. Fintel, 2008 .

Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.

Michael A. Burke, D. Fintel, Richard J. Lee, 2011, American heart journal.

Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis.

L. Becker, J. Links, J. Brinker, 1989, Journal of the American College of Cardiology.

Comparison of twelve-lead electrocardiogram using a glove-based recording system with standard methodology.

Victor Mor-Avi, Roberto M Lang, Michael Luc, 2013, The American journal of cardiology.

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123

M. Suntharalingam, R. Ivker, W. Small, 2016, American journal of clinical oncology.

EFFECT OF METOPROLOL VERSUS CARVEDILOL ON SURVIVAL AFTER MYOCARDIAL INFARCTION

H. Subacius, J. Goldberger, D. Fintel, 2016 .

Tissue factor in cultured cells: pharmacologic effects.

Y. Nemerson, D. Fintel, F. Pitlick, 1976, Laboratory investigation; a journal of technical methods and pathology.

Usefulness of single-photon emission computed tomography of thallium-201 uptake after dipyridamole infusion for detection of coronary artery disease.

D. Fintel, W. Spies, S. Spies, 1992, The American journal of cardiology.

Adverse Reactions to Thrombolytic Agents

D. Fintel, R. Davison, K. Kaplan, 1987, Medical toxicology and adverse drug experience.

Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization.

C. Bennett, D. Fintel, S. Meyers, 2003, The Journal of invasive cardiology.

D. Morrow, J. López-Sendón, D. Fintel, 2012 .

Cardiologists Use Pulmonary Artery Catheter Information to Make Homogenous Treatment Decisions

D. Fintel, D. Upadhyay, B. Jovanovic, 2007, Journal of intensive care medicine.

Heart rate variability 1989. An update.

D H Singer, G J Martin, D. Singer, 1989, Journal of electrocardiology.

A double-blind, randomized comparison of anistreplase and alteplase in acute myocardial infarction: Coronary patency results from the team-3 study

Jeffrey L. Anderson, P. Shah, D. Morris, 1991 .

Tissue factor in cultured cells: metabolic control.

Y. Nemerson, D. Fintel, F. Pitlick, 1976, Laboratory investigation; a journal of technical methods and pathology.